Federal Supply Schedule 36F79723D0188

Award Date 8/15/23
Last Date to Order 8/14/28
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a Federal Supply Schedule (FSS) contract administered by the Department of Veterans Affairs Veterans Health Administration (VA VHA). The prime contractor, Mylan Specialty LP, was awarded a multiple award FSS contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, with a ceiling value of $514,849,130 and a period of performance running through January 2027. The contract enables the VA to issue task orders to procure pharmaceuticals, drugs, hematology...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company. The contract, designated as V797D70253, falls under the Pharmaceuticals and Drugs FSS (FSS-61-IB), a government-wide acquisition vehicle. The task orders issued under this contract demonstrate Fresenius Kabi USA, LLC's role as a critical supplier of injectable pharmaceutical products, including...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, a foreign-owned for-profit pharmaceutical manufacturer. The contract, valued at $5,892,883.55, was awarded on September 27, 2024 by the Defense Logistics Agency (DLA) and has an ultimate completion date of September 26, 2029. Under this IDC, Specgx primarily provides the Department of Veterans Affairs (VA), Department of Defense, Bureau of...
The federal contract IDV award is a $7.31 billion Federal Supply Schedule contract with the Department of Veterans Affairs (VA) awarded to Pfizer Inc., a large pharmaceutical manufacturer. The contract covers a wide range of pharmaceutical products including controlled substances, antibiotics, pain medications, anti-nausea drugs, hormone treatments, and emergency medical interventions. This IDV contract allows Pfizer to deliver critical healthcare supplies across various government agencies such...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Nobelpharma America, LLC, a foreign-owned, self-certified small disadvantaged business. The FSS contract, under Federal Supply Class 65 I B, provides for the delivery of pharmaceutical and hematology-related products to VA facilities nationwide, with a ceiling value of $225,000 and a period of performance through May 2028. Additionally, Nobelpharma America, LLC was awarded a...
The blanket purchase agreement between the Drug Enforcement Administration and Mountainside Medical Equipment, Inc. provides for the procurement of various medical supplies and pharmaceutical products to support the DEA's operations. Task orders awarded against the IDV include the purchase of Narcan nasal spray kits, medical equipment, replacement storage boxes, and training supplies valued collectively at over $100,000. Performance locations encompass DEA facilities in New York, Virginia, and...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract was awarded to Amarin Pharma, Inc., a for-profit organization, with a period of performance from September 1, 2024 to August 31, 2029. The contract has a ceiling value of $1,844,760.00 and covers the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS contract...
The federal contract IDV in question is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. government. The contract, valued at a ceiling of $633,260.00, was awarded to Curae Pharma360 Inc. on July 15, 2023, with a period of performance ending on July 31, 2024. The contract is classified as 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, indicating that it covers the procurement of...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Tonix Medicines, Inc. The contract has a period of performance from August 1, 2024 to July 31, 2029 and a ceiling value of $250,000.00. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. As an FSS contract, it allows for the purchase of the awarded products and services by various federal...
  • 36F79723D0188
    Federal Supply Schedule
  • -
    Blanket Purchase Agreements
  • 5
    Federal Contract Awards

The federal contract IDV described is a Multiple Award Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer. The $11.8 million contract, running through August 2028, is for Schedule 65 IB pharmaceuticals, drugs, and hematology-related products, with a focus on naloxone products used to reverse opioid overdoses.

Under this IDV, Emergent Devices has received numerous delivery orders from federal agencies including the VA, Federal Emergency Management Agency (FEMA), Department of Homeland Security (DHS), Immigration and Customs Enforcement (ICE), and Customs and Border Protection (CBP) to procure NARCAN nasal spray and other naloxone formulations. These orders, valued between $15,000 to $163,000, support the government's public health and safety initiatives to address the opioid crisis. Additionally, Emergent Devices holds a $250,000 single-award Blanket Purchase Agreement with the Department of the Navy Criminal Investigative Service for NARCAN nasal spray, further demonstrating the federal government's commitment to ensuring a reliable supply of these critical overdose reversal medications across multiple agencies.

Generated 4/9/25, 9:49 AM